Latest News

Some of the news articles below may show only part of the news story. To view the full story, click on Read More below the story. 

  • April 15, 2019 11:46 AM | Deleted user

    April 15, 2019
    Submitted by APAOG Publications Chair Heather Adams 


    Endocrine Society Guidelines 

    The Endocrine Society recently used clinical trial data and clinical expertise to formulate new guidelines for the treatment of postmenopausal osteoporosis. 

    Read more.

    PAs and Medical Malpractice Claims

    A new trend has been identified; Physician Assistants are being increasingly targeted or singled out by the Personal Injury Bar for medical malpractice claims.  

    Read more. 

    FDA Approves expanded us of Gardasil9® 

    It’s official! The FDA has approved the expanded age indication for Gardasil 9®, which is now indicated for females and males from age 9 years to 45 years of age.  

      

    Read more.


  • April 15, 2019 9:42 AM | Deleted user

    April 15, 2019, HemOnc Today 

    HPV infection drove a recent increase in glottic carcinoma incidence among individuals aged 30 years and younger, according to results of a retrospective study published in in Annals of Otology, Rhinology & Laryngology. 

    Read more.


  • April 15, 2019 9:40 AM | Deleted user

    April 15, 2019, MedPage Today OB/GYN Update  

    Women ages 50 to 74 at average risk for breast cancer should undergo screening mammography every other year, according to the latest guidance from the American College of Physicians (ACP), recommendations that were met with immediate pushback from the radiology community. 

    Read more. 

  • April 12, 2019 10:51 AM | Deleted user

    April 12, 2019, Infectious Disease News via Healio  

    The IV formulation of fosfomycin was found to be effective in treating complicated UTIs, including acute pyelonephritis, compared with IV piperacillin-tazobactam, according to research published in Clinical Infectious Diseases

    Read more.

  • April 10, 2019 9:48 AM | Deleted user

    April 10, 2019, MedPage Today

    WASHINGTON -- The FDA approved romosozumab (Evenity) for osteoporosis in postmenopausal women at high risk for fracture, the agency announced Tuesday

    Read more.

  • April 10, 2019 9:44 AM | Deleted user

    April 10, 2019, University of Western Ontario, via Medical Xpress 

    New technology developed at Western University is providing an improved way for radiation oncologists to deliver treatment to women with gynaecological cancers, including vaginal, cervical, and uterine cancer. 

    Read more.


  • April 10, 2019 8:38 AM | Deleted user

    April 10, 2019, Primary Care Today

    The "simple, non-invasive" Congo Red Dot Paper Test detected preeclampsia in 3 minutes, significantly faster than the current gold standard, according to findings recently published in EClinical Medicine.

    Read more.
  • April 08, 2019 9:42 AM | Deleted user

    April 8, 2019, MedPage Today 

    Within the 5 years following a diagnosis for stage I or II breast cancer, 21% of patients stop seeing physicians for follow-up care, according to a study in the Journal of Oncology Practice

    Read more.

  • April 02, 2019 3:34 PM | Deleted user

    April 2, 2019, MedPage Today 

    Total deaths for women with HIV and their children are projected to be lower with dolutegravir-based (Tivicay) antiretroviral therapy (ART) versus efavirenz-based (Sustiva) ART, a model-based analysis found. 

    Read more.

  • March 29, 2019 8:27 AM | Deleted user

    March 29, 2019, HealthDay News 

    A new study suggests that the fewer menstrual periods a woman has in her lifetime, the higher her risk of dementia — though the reasons, for now, are unclear. The study was based on close to 16,000 women. It found that those who started having periods at age 16 or later were more likely to develop dementia than women who started menstruating at a more typical age. The same was true of women who went through menopause relatively early. 

    Read more.

Powered by Wild Apricot Membership Software